Guidelines for cost-effective prostate specific antigen (PSA)-based screening programs in low- and middle-income nations exist and can be used as a framework for implementing a screening in refugee populations, with principles including interpreting PSA levels according to age, screening less frequently, and increasing prostate cancer awareness in the target population with accompanying education programs (15). The gene discussed is KLK3; the disease is prostate cancer.